Search

Your search keyword '"Dupuy, Aurélie"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Dupuy, Aurélie" Remove constraint Author: "Dupuy, Aurélie"
34 results on '"Dupuy, Aurélie"'

Search Results

1. Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?

2. The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

3. Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?

4. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study

5. Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection

6. Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

7. High prevalence of unusual KRAS , NRAS , and BRAF mutations in POLE‐hypermutated colorectal cancers

9. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay

11. Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases

12. Defining the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression profiling assay (RT-MLPA)

13. RNA fusions involving are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells

14. Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay

15. Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring

16. Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

17. RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells

18. Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas

19. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

21. Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category

22. Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas.

23. Overcoming Transcription Activator-like Effector (TALE) DNA Binding Domain Sensitivity to Cytosine Methylation

25. Stabilisation de l'interface liquide-liquide dans un contacteur membranaire : Application à l'extraction sélective de terpènes oxygénés d'huile essentielle d'agrumes

27. Multiple Ways to Detect IDH2Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

30. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients

31. Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2Mutation Detection and Monitoring

32. Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.

33. Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.

34. Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation.

Catalog

Books, media, physical & digital resources